{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T18:04:47Z","timestamp":1771956287002,"version":"3.50.1"},"reference-count":36,"publisher":"Federa\u00e7\u00e3o das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,23]]},"DOI":"10.61622\/rbgo\/2026rbgo13","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:14:04Z","timestamp":1771953244000},"source":"Crossref","is-referenced-by-count":0,"title":["Vaginal pixel CO2 laser versus topical use of promestriene for genitourinary syndrome of menopause"],"prefix":"10.61622","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7216-2170","authenticated-orcid":false,"given":"K\u00e1tia","family":"Beckhauser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6003-3043","authenticated-orcid":false,"given":"Marina Gules","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1039-7940","authenticated-orcid":false,"given":"Edison","family":"Capp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7249-7800","authenticated-orcid":false,"given":"L\u00facia Maria","family":"Kliemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9085-4605","authenticated-orcid":false,"given":"Maria Celeste Os\u00f3rio","family":"Wender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"47794","reference":[{"issue":"10","key":"key20260224171357_B1","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/GME.0000000000000319","article-title":"The North American Menopause Society recommendations for clinical care of midlife women","volume":"21","author":"Shifren","year":"2014","unstructured":"1 Shifren JL, Gass ML; NAMS Recommendations for Clinical Care of Midlife Women Working Group. The North American Menopause Society recommendations for clinical care of midlife women. Menopause. 2014;21(10):1038-62. doi: 10.1097\/GME.0000000000000319","journal-title":"Menopause"},{"issue":"10","key":"key20260224171357_B2","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/GME.0000000000000329","article-title":"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society","volume":"21","author":"Portman","year":"2014","unstructured":"2 Portman DJ, Gass ML; Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Menopause. 2014;21(10):1063-8. doi: 10.1097\/GME.0000000000000329","journal-title":"Menopause"},{"issue":"2","key":"key20260224171357_B3","article-title":"Study of vulvovaginal atrophy and genitourinary syndrome of menopause and its impact on the quality of life of postmenopausal women in Central India","volume":"16","author":"Ulhe","year":"2024","unstructured":"3 Ulhe SC, Acharya N, Vats A, Singh A. Study of vulvovaginal atrophy and genitourinary syndrome of menopause and its impact on the quality of life of postmenopausal women in Central India. Cureus. 2024;16(2):e54802. doi: 10.7759\/cureus.54802","journal-title":"Cureus"},{"issue":"6","key":"key20260224171357_B4","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1586\/eog.12.64","article-title":"The role of local vaginal estrogen treatment in urogenital atrophy","volume":"7","author":"Ulrich","year":"2012","unstructured":"4 Ulrich L. The role of local vaginal estrogen treatment in urogenital atrophy. Expert Rev Obstet Gynecol. 2012;7(6):545-56.","journal-title":"Expert Rev Obstet Gynecol"},{"issue":"1","key":"key20260224171357_B5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10103-014-1677-2","article-title":"Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment","volume":"30","author":"Zerbinati","year":"2015","unstructured":"5 Zerbinati N, Serati M, Origoni M, Candiani M, Iannitti T, Salvatore S, et al. Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment. Lasers Med Sci. 2015;30(1):429-36. doi: 10.1007\/s10103-014-1677-2","journal-title":"Lasers Med Sci"},{"issue":"3","key":"key20260224171357_B6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/pho.2016.4173","article-title":"Fractional CO(2) laser: from skin rejuvenation to vulvo-vaginal reshaping","volume":"35","author":"Filippini","year":"2017","unstructured":"6 Filippini M, Del Duca E, Negosanti F, Bonciani D, Negosanti L, Sannino M, et al. Fractional CO(2) laser: from skin rejuvenation to vulvo-vaginal reshaping. Photomed Laser Surg. 2017;35(3):171-5. doi: 10.1089\/pho.2016.4173","journal-title":"Photomed Laser Surg"},{"issue":"11","key":"key20260224171357_B7","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.3390\/jcm12113679","article-title":"Fractional CO(2) laser treatment is safe and effective for the management of genitourinary syndrome of menopause in Korean women","volume":"12","author":"Chung","year":"2023","unstructured":"7 Chung YJ, Shim S, Kim S, Cha J, Song JY, Kim MJ, et al. Fractional CO(2) laser treatment is safe and effective for the management of genitourinary syndrome of menopause in Korean women. J Clin Med. 2023;12(11):3679. doi: 10.3390\/jcm12113679","journal-title":"J Clin Med"},{"issue":"3","key":"key20260224171357_B8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/GME.0000000000001206","article-title":"Microablative fractional CO2 laser for the genitourinary syndrome of menopause: up to 12-month results","volume":"26","author":"Athanasiou","year":"2019","unstructured":"8 Athanasiou S, Pitsouni E, Grigoriadis T, Zacharakis D, Falagas ME, Salvatore S, et al. Microablative fractional CO2 laser for the genitourinary syndrome of menopause: up to 12-month results. Menopause. 2019;26(3):248-55. doi: 10.1097\/GME.0000000000001206","journal-title":"Menopause"},{"issue":"1","key":"key20260224171357_B9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/LGT.0000000000000162","article-title":"Normal vulvar histology: variation by site","volume":"20","author":"Day","year":"2016","unstructured":"9 Day T, Holland SM, Scurry J. Normal vulvar histology: variation by site. J Low Genit Tract Dis. 2016;20(1):64-9. doi: 10.1097\/LGT.0000000000000162","journal-title":"J Low Genit Tract Dis"},{"issue":"6","key":"key20260224171357_B10","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/GCO.0000000000000230","article-title":"The use of pulsed CO2 lasers for the treatment of vulvovaginal atrophy","volume":"27","author":"Salvatore","year":"2015","unstructured":"10 Salvatore S, Athanasiou S, Candiani M. The use of pulsed CO2 lasers for the treatment of vulvovaginal atrophy. Curr Opin Obstet Gynecol. 2015;27(6):504-8. doi: 10.1097\/GCO.0000000000000230","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"7","key":"key20260224171357_B11","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3390\/cancers17071241","article-title":"CO(2) laser therapy for genitourinary syndrome of menopause in women with breast cancer: a randomized, sham-controlled trial","volume":"17","author":"Jaber","year":"2025","unstructured":"11 Jaber S, Levin G, Ram-Weiner M, Lev-Sagie A. CO(2) laser therapy for genitourinary syndrome of menopause in women with breast cancer: a randomized, sham-controlled trial. Cancers (Basel). 2025;17(7):1241. doi: 10.3390\/cancers17071241","journal-title":"Cancers (Basel)"},{"issue":"1","key":"key20260224171357_B12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3892\/etm.2023.12297","article-title":"Carbon dioxide laser therapy for the management of genitourinary syndrome of menopause: a meta-analysis of randomized controlled trials","volume":"27","author":"Ni","year":"2024","unstructured":"12 Ni Y, Lian J. Carbon dioxide laser therapy for the management of genitourinary syndrome of menopause: a meta-analysis of randomized controlled trials. Exp Ther Med. 2024;27(1):10. doi: 10.3892\/etm.2023.12297","journal-title":"Exp Ther Med"},{"issue":"4","key":"key20260224171357_B13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/13697137.2025.2455186","article-title":"Laser for genitourinary syndrome of menopause: what we know and what we need to know","volume":"28","author":"Li","year":"2025","unstructured":"13 Li FG, Abbott J. Laser for genitourinary syndrome of menopause: what we know and what we need to know. Climacteric. 2025;28(4):414-22. doi: 10.1080\/13697137.2025.2455186","journal-title":"Climacteric"},{"issue":"2","key":"key20260224171357_B14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/lsm.22569","article-title":"Efficacy of Erbium: YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause","volume":"49","author":"Gaspar","year":"2017","unstructured":"14 Gaspar A, Brandi H, Gomez V, Luque D. Efficacy of Erbium: YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Lasers Surg Med. 2017;49(2):160-8. doi: 10.1002\/lsm.22569","journal-title":"Lasers Surg Med"},{"issue":"5","key":"key20260224171357_B15","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s10103-018-2471-3","article-title":"Fractional CO(2) laser for genitourinary syndrome of menopause in breast cancer survivors: clinical, immunological, and microbiological aspects","volume":"33","author":"Becorpi","year":"2018","unstructured":"15 Becorpi A, Campisciano G, Zanotta N, Tredici Z, Guaschino S, Petraglia F, et al. Fractional CO(2) laser for genitourinary syndrome of menopause in breast cancer survivors: clinical, immunological, and microbiological aspects. Lasers Med Sci. 2018;33(5):1047-54. doi: 10.1007\/s10103-018-2471-3","journal-title":"Lasers Med Sci"},{"issue":"1","key":"key20260224171357_B16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/GME.0000000000000955","article-title":"Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women","volume":"25","author":"Cruz","year":"2018","unstructured":"16 Cruz VL, Steiner ML, Pompei LM, Strufaldi R, Fonseca FL, Santiago LH, et al. Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women. Menopause. 2018;25(1):21-8. doi: 10.1097\/GME.0000000000000955","journal-title":"Menopause"},{"issue":"2","key":"key20260224171357_B17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5978\/islsm.28_19-OR-06","article-title":"Long-term safety and efficacy of fractional CO(2) laser treatment in post-menopausal women with vaginal atrophy","volume":"28","author":"Eder","year":"2019","unstructured":"17 Eder SE. Long-term safety and efficacy of fractional CO(2) laser treatment in post-menopausal women with vaginal atrophy. Laser Ther. 2019;28(2):103-9. doi: 10.5978\/islsm.19-OR-06","journal-title":"Laser Ther"},{"issue":"1","key":"key20260224171357_B18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/GME.0000000000001428","article-title":"Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study","volume":"27","author":"Filippini","year":"2020","unstructured":"18 Filippini M, Luvero D, Salvatore S, Pieralli A, Montera R, Plotti F, et al. Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study. Menopause. 2020;27(1):43-9. doi: 10.1097\/GME.0000000000001428","journal-title":"Menopause"},{"issue":"3","key":"key20260224171357_B19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/13697137.2018.1559806","article-title":"Rationale and design for fractional microablative CO(2) laser versus photothermal non-ablative erbium: YAG laser for the management of genitourinary syndrome of menopause: a non-inferiority, single-blind randomized controlled trial","volume":"22","author":"Flint","year":"2019","unstructured":"19 Flint R, Cardozo L, Grigoriadis T, Rantell A, Pitsouni E, Athanasiou S. Rationale and design for fractional microablative CO(2) laser versus photothermal non-ablative erbium: YAG laser for the management of genitourinary syndrome of menopause: a non-inferiority, single-blind randomized controlled trial. Climacteric. 2019;22(3):307-11. doi: 10.1080\/13697137.2018.1559806","journal-title":"Climacteric"},{"issue":"1","key":"key20260224171357_B20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/GME.0000000000001416","article-title":"A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial","volume":"27","author":"Paraiso","year":"2020","unstructured":"20 Paraiso MF, Ferrando CA, Sokol ER, Rardin CR, Matthews CA, Karram MM, et al. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial. Menopause. 2020;27(1):50-6. doi: 10.1097\/GME.0000000000001416","journal-title":"Menopause"},{"issue":"8","key":"key20260224171357_B21","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/GME.0000000000001333","article-title":"Fractional CO2 laser versus promestriene and lubricant in genitourinary syndrome of menopause: a randomized clinical trial","volume":"26","author":"Politano","year":"2019","unstructured":"21 Politano CA, Costa-Paiva L, Aguiar LB, Machado HC, Baccaro LF. Fractional CO2 laser versus promestriene and lubricant in genitourinary syndrome of menopause: a randomized clinical trial. Menopause. 2019;26(8):833-40. doi: 10.1097\/GME.0000000000001333","journal-title":"Menopause"},{"issue":"3","key":"key20260224171357_B22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.tjog.2025.02.002","article-title":"The efficacy of fractional CO(2) laser treatment on postpartum vulvovaginal atrophy: a prospective observational study","volume":"64","author":"Huang","year":"2025","unstructured":"22 Huang WC, Su CY, Wang YL. The efficacy of fractional CO(2) laser treatment on postpartum vulvovaginal atrophy: a prospective observational study. Taiwan J Obstet Gynecol. 2025;64(3):463-8. doi: 10.1016\/j.tjog.2025.02.002","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"2","key":"key20260224171357_B23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/lsm.22637","article-title":"Light and energy based therapeutics for genitourinary syndrome of menopause: consensus and controversies","volume":"49","author":"Tadir","year":"2017","unstructured":"23 Tadir Y, Gaspar A, Lev-Sagie A, Alexiades M, Alinsod R, Bader A, et al. Light and energy based therapeutics for genitourinary syndrome of menopause: consensus and controversies. Lasers Surg Med. 2017;49(2):137-59. doi: 10.1002\/lsm.22637","journal-title":"Lasers Surg Med"},{"issue":"4","key":"key20260224171357_B24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.sxmr.2017.07.003","article-title":"Sexual function in women suffering from genitourinary syndrome of menopause treated with fractionated CO(2) laser","volume":"5","author":"Salvatore","year":"2017","unstructured":"24 Salvatore S, Pitsouni E, Del Deo F, Parma M, Athanasiou S, Candiani M. Sexual function in women suffering from genitourinary syndrome of menopause treated with fractionated CO(2) laser. Sex Med Rev. 2017;5(4):486-94. doi: 10.1016\/j.sxmr.2017.07.003","journal-title":"Sex Med Rev"},{"issue":"2","key":"key20260224171357_B25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/gyn.2018.0048","article-title":"Effects of vulvovaginal laser therapy on postmenopausal vaginal atrophy: a prospective study","volume":"35","author":"Singh","year":"2018","unstructured":"25 Singh P, Chong CY, Han HC. Effects of vulvovaginal laser therapy on postmenopausal vaginal atrophy: a prospective study. J Gynecol Surg. 2018;35(2):99-104.","journal-title":"J Gynecol Surg"},{"issue":"12","key":"key20260224171357_B26","first-page":"2491","article-title":"Is vaginal fractional CO2 laser treatment effective in improving overactive bladder symptoms in post-menopausal patients? Preliminary results","volume":"20","author":"Perino","year":"2016","unstructured":"26 Perino A, Cucinella G, Gugliotta G, Saitta S, Polito S, Adile B, et al. Is vaginal fractional CO2 laser treatment effective in improving overactive bladder symptoms in post-menopausal patients? Preliminary results. Eur Rev Med Pharmacol Sci. 2016;20(12):2491-7.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key20260224171357_B27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejogrb.2017.03.036","article-title":"Safety and long-term efficacy of fractional CO(2) laser treatment in women suffering from genitourinary syndrome of menopause","volume":"213","author":"Behnia-Willison","year":"2017","unstructured":"27 Behnia-Willison F, Sarraf S, Miller J, Mohamadi B, Care AS, Lam A, et al. Safety and long-term efficacy of fractional CO(2) laser treatment in women suffering from genitourinary syndrome of menopause. Eur J Obstet Gynecol Reprod Biol. 2017;213:39-44. doi: 10.1016\/j.ejogrb.2017.03.036","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"key20260224171357_B28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/13697137.2016.1212006","article-title":"The effect of microablative fractional CO2 laser on vaginal flora of postmenopausal women","volume":"19","author":"Athanasiou","year":"2016","unstructured":"28 Athanasiou S, Pitsouni E, Antonopoulou S, Zacharakis D, Salvatore S, Falagas ME, et al. The effect of microablative fractional CO2 laser on vaginal flora of postmenopausal women. Climacteric. 2016;19(5):512-8. doi: 10.1080\/13697137.2016.1212006","journal-title":"Climacteric"},{"issue":"8","key":"key20260224171357_B29","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/lsm.23211","article-title":"The effect of vaginal microablative fractional CO(2) laser treatment on vaginal cytology","volume":"52","author":"Takacs","year":"2020","unstructured":"29 Takacs P, Sipos AG, Kozma B, Cunningham TD, Larson K, Lamp\u00e9 R, et al. The effect of vaginal microablative fractional CO(2) laser treatment on vaginal cytology. Lasers Surg Med. 2020;52(8):708-12. doi: 10.1002\/lsm.23211","journal-title":"Lasers Surg Med"},{"issue":"2","key":"key20260224171357_B30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/13697137.2018.1436538","article-title":"Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause","volume":"21","author":"Gambacciani","year":"2018","unstructured":"30 Gambacciani M, Levancini M, Russo E, Vacca L, Simoncini T, Cervigni M. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause. Climacteric. 2018;21(2):148-52. doi: 10.1080\/13697137.2018.1436538","journal-title":"Climacteric"},{"issue":"3","key":"key20260224171357_B31","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.maturitas.2014.12.006","article-title":"Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser","volume":"80","author":"Perino","year":"2015","unstructured":"31 Perino A, Calligaro A, Forlani F, Tiberio C, Cucinella G, Svelato A, et al. Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser. Maturitas. 2015;80(3):296-301. doi: 10.1016\/j.maturitas.2014.12.006","journal-title":"Maturitas"},{"issue":"4","key":"key20260224171357_B32","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00404-016-4118-6","article-title":"Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors","volume":"294","author":"Pieralli","year":"2016","unstructured":"32 Pieralli A, Fallani MG, Becorpi A, Bianchi C, Corioni S, Longinotti M, et al. Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors. Arch Gynecol Obstet. 2016;294(4):841-6. doi: 10.1007\/s00404-016-4118-6","journal-title":"Arch Gynecol Obstet"},{"key":"key20260224171357_B33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejogrb.2017.01.031","article-title":"CO2-laser therapy in women with severe symptoms of vaginal atrophy: a pilot histopathological study","volume":"211","author":"Pitsouni","year":"2017;","unstructured":"33 Pitsouni E, Grigoriadis T, Zacharakis D, Tsiveleka A, Danas E, Theocharis S, et al. CO2-laser therapy in women with severe symptoms of vaginal atrophy: a pilot histopathological study. Eur J Obstet Gynecol Reprod Biol. 2017;211:201. doi: 10.1016\/j.ejogrb.2017.01.031","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"key20260224171357_B34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-019-05384-9","article-title":"Vaginal CO(2) laser for the treatment of vulvovaginal atrophy in women with breast cancer: LAAVA pilot study","volume":"178","author":"Pearson","year":"2019","unstructured":"34 Pearson A, Booker A, Tio M, Marx G. Vaginal CO(2) laser for the treatment of vulvovaginal atrophy in women with breast cancer: LAAVA pilot study. Breast Cancer Res Treat. 2019;178(1):135-40. doi: 10.1007\/s10549-019-05384-9","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"key20260224171357_B35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/lsm.23066","article-title":"Efficacy of fractional CO(2) laser in the treatment of genitourinary syndrome of menopause in Latin-American Population: first Peruvian experience","volume":"51","author":"Tovar-Huamani","year":"2019","unstructured":"35 Tovar-Huamani J, Mercado-Olivares F, Grandez-Urbina JA, Pichardo-Rodriguez R, Tovar-Huamani M, Garc\u00eda-Perdomo H. Efficacy of fractional CO(2) laser in the treatment of genitourinary syndrome of menopause in Latin-American Population: first Peruvian experience. Lasers Surg Med. 2019;51(6):509-15. doi: 10.1002\/lsm.23066","journal-title":"Lasers Surg Med"},{"issue":"5","key":"key20260224171357_B36","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4236\/jct.2017.85039","article-title":"Evaluation of the CO2 laser therapy on Vulvo-Vaginal Atrophy (VVA) in oncological patients: preliminary results","volume":"8","author":"Pagano","year":"2017","unstructured":"36 Pagano I, Gieri S, Nocera F, Scibilia G, Fraggetta F, Galia A, et al. Evaluation of the CO2 laser therapy on Vulvo-Vaginal Atrophy (VVA) in oncological patients: preliminary results. J Cancer Ther. 2017;8(5):452-63. doi: 10.4236\/jct.2017.85039","journal-title":"J Cancer Ther"}],"container-title":["Revista Brasileira de Ginecologia e Obstetr\u00edcia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:14:09Z","timestamp":1771953249000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalrbgo.org\/article\/vaginal-pixel-co2-laser-versus-topical-use-of-promestriene-for-genitourinary-syndrome-of-menopause\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":36,"alternative-id":["10.61622\/rbgo\/2026rbgo13"],"URL":"https:\/\/doi.org\/10.61622\/rbgo\/2026rbgo13","relation":{},"ISSN":["0100-7203","1806-9339"],"issn-type":[{"value":"0100-7203","type":"print"},{"value":"1806-9339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e-rbgo13"}}